Leptomeningeal metastases—What outcomes should we measure and how?

Rimas V. Lukas

doi:10.1093/neuonc/noac101

Leptomeningeal metastases—What outcomes should we measure and how?

Rimas V. Lukas^*

^*Corresponding author for this work

Neurology

Research output: Contribution to journal › Editorial › peer-review

4 Scopus citations

Original language	English (US)
Pages (from-to)	1736-1737
Number of pages	2
Journal	Neuro-oncology
Volume	24
Issue number	10
DOIs	https://doi.org/10.1093/neuonc/noac101
State	Published - Oct 1 2022

ASJC Scopus subject areas

Oncology
Clinical Neurology
Cancer Research

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1093/neuonc/noac101

Cite this

@article{72b9923493e94ec291576834ab47e46c,

title = "Leptomeningeal metastases—What outcomes should we measure and how?",

author = "Lukas, {Rimas V.}",

year = "2022",

month = oct,

day = "1",

doi = "10.1093/neuonc/noac101",

language = "English (US)",

volume = "24",

pages = "1736--1737",

journal = "Neuro-oncology",

issn = "1522-8517",